Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Assembly Biosciences

Clinical trials sponsored by Assembly Biosciences, explained in plain language.

Assembly Biosciences ASMB NASDAQ

A clinical-stage biotechnology company developing therapies for hepatitis B virus and other viral diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Completed 3

Can a daily pill tame hepatitis d?

Disease control Not yet recruiting

This Phase 2 trial is testing an experimental oral drug called ABI-6250 in about 80 people with chronic hepatitis D, a serious liver infection. Participants take the pill once daily for 48 weeks. The study aims to see if the drug is safe, how it moves through the body, and whethe…

Phase: PHASE2 • Sponsor: Assembly Biosciences • Aim: Disease control

Last updated Aug 15, 2026 00:00 UTC